Christopher Brightling
University of Leicester · Institute for Lung Health, United Kingdom · Institute for Lung Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher Brightling as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:16 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT04075331 · Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic TrialUniversity of Leicester · completed · COPD, Eosinophilia · study chair
- Ph1NCT03851250 · A Study of MRx-4DP0004 in Asthma4D pharma plc · terminated · Asthma · principal investigator
- Ph2NCT03615040 · Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP)University of Leicester · completed · COPD Exacerbation · principal investigator
- Ph2NCT02449473 · Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on CorticosteroidsAstraZeneca · completed · Asthma · principal investigator
- Ph3NCT02194699 · A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled AsthmaAstraZeneca · completed · Uncontrolled Asthma · principal investigator
- Ph2NCT01402986 · A Safety and Efficacy Study of Tralokinumab in Adults With AsthmaMedImmune LLC · completed · Asthma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:16 UTC. The ranking covers the 200 most relevant of 70 PubMed records, and a shared surname and initials can bring in a namesake. All 70 on PubMed
- Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med · 20218,207 citationsRCR 570.9
- Mepolizumab and exacerbations of refractory eosinophilic asthma.N Engl J Med · 20091,470 citationsRCR 39.4
- 1,373 citationsRCR 33.7
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.N Engl J Med · 2021885 citationsRCR 61.1
- 678 citationsRCR 30.5
- Evidence of a role of tumor necrosis factor alpha in refractory asthma.N Engl J Med · 2006671 citationsRCR 16.6
- 664 citationsRCR 14.8
- Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.Am J Respir Crit Care Med · 2012515 citationsRCR 16.7
- 467 citationsRCR 12.0
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.Lancet Respir Med · 2016448 citationsRCR 18.0